CYTO Altamira Therapeutics Ltd.

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.

$0.49  -0.02 (-4.84%)
As of 06/30/2022 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Bermuda
Country of incorporation:  Bermuda
IPO date:  08/06/2014
Outstanding shares:  14,964,261
Average volume:  545,848
Market cap:   $7,631,773
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.57
PS ratio:   0.00
Return on equity:   -115.18%
Net income %:   0.00%